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markers have been identified to be associated with increased
incidence of cardiovascular complications and death in patients
with ACS and increased severity of coronary artery lesion. Among
these biomarkers some have emerged to be potentially useful in
early risk assessment of patients with ACS, such as CRP, B type
natriuretic peptide, troponin T/I, interleukin 6, and white blood
cell (WBC) count and among these WBC count is the simplest.
Although total leukocyte count is an established prognostic
marker of ACS, there are limited studies for differential neutrophil
count and prognosis in ACS.
Methods: 202 consecutive patients admitted with a diagnosis of
ACS were evaluated by history and physical examination. Venous
blood was drawn from all the patients at the time of admission
and was analysed for CK-MB, Troponin T and Total leukocyte
count and differential leukocyte count. The neutrophil counts
were assigned into three categories, N1 (<70%), N2 (70-90%) andN3
(90%): Coronary angiography was carried out within 24 hours of
admission.
Results: The Neutrophil count ranged from 45% to 98%. The me-
dian neutrophil count was 78%; Smokers had a higher neutrophil
count than non-smokers. Neutrophil count also tended to be
higher in patients who died within 7 days (P<0.001). The devel-
opment of new CHF or shock was associated with a higher
Neutrophil count (P<0.001) Patients with a closed infarct-related
artery on angiography (TIMI grade 0 or 1 flow) had a higher
neutrophil count than did patients with an open artery (P<0.001).
The presence of angiographically apparent thrombus was asso-
ciated with a higher Neutrophil count than those without
thrombus. (82%, n¼28 versus 68%, n¼72) (p<.01)
Conclusion: The results of the present study confirm previous
observations that relate elevated WBC count to adverse clinical
outcomes in patients with ACS and further explore the patho-
physiology that underlies this relationship. In addition to the
worse clinical outcome, reduced patency and greater thrombus
burden seen in patients with an elevated Neutrophil count, these
patients had poorer downstream microvascular perfusion as
assessed with TIMI perfusion grade. It is possible that this
impaired myocardial perfusion reflects neutrophilemediated
endothelial dysfunction andmicrovascular plugging, as described
in animal models of ischemia-reperfusion.
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Background: Myocardial infarction (MI) is leading cause of death
worldwide. Moreover, in India the average age of acutemyocardial
infarction (AMI) has reduced to 50 indicating it as a grave public
health concern. The objective of our studywas to identify genomic
variants associated with AMI in patients from Western India in
genome wide association study (GWAS) and validating the iden-
tified single nucleotide polymorphisms (SNPs), using high-
throughput DNA microarray analysis.
Methods: Initially, 48 AMI patients and 48 controls were screened
for SNPs using Illumina human CVD55K beadchip, containing
approximately 50,000 human SNPs probes. The identified SNPs
were then further validated by genotyping additional 188 patients
and 196 controls using custom based Illumina’s VeraCode Gold-
enGate Genotyping Assay. PLINK software was used to perform
statistical analysis.
Results: On normalization and filtration of the preliminary
microarray data, 98 SNPs of 94 genes were identified associated
with AMI (odds ratio range of 1.84-8.85, p value 0.0486 to 0.00334).
Eight of these 98 SNPs reproduced association (p<0.05). The genes
associated with some SNPs encoded for the proteins linked with
blood coagulation, innate immunity, troponin complex and in-
flammatory pathways.
Conclusion: The study identified 8 SNPs associated with AMI
which may increase the susceptibility towards the disease in pa-
tients from Western India.
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Objectives: We aimed to analyze the effect of reperfusion of
infarct related artery on the TpTe interval determined on the
surface 12 lead ECG. We also studied the association of Major
adverse cardiac events (MACE) with repolarization abnormality on
the ECG.
Methods: Patients with new onset STEMI treated with thrombol-
ysis or primary/ rescue PCI were included. Digital ECGs at 50 mm/
sec speed and 20 mm/mV gain filtered at 0.50e150Hz were taken
before and after reperfusion therapy. TpTe interval wasmeasured
in leads with limited ST-segment deviation. All patients were
followed up at 30 days.
Results: From June 2013 to December 2013, total of 216 patients
were included of which 183 were males (85.1%). The mean age
was 54.86 years (range 24-80 years). One hundred and thirteen
patients underwent primary PCI (52.3%), 57 lysis (26.4%) and
remaining 46(21.3%) rescue PCI. Thirty day Mortality was 5.1 %
(11 patients). The pre TpTe interval was 84.50ms (IQR 80 - 100
ms) and the mean TpTe intervals reduced following interven-
tion; primary PCI (74.93ms, p <0.001), thrombolysis (72.76,
p<0.001) and rescue PCI groups (72.86 ms, p¼0.004). Of the 216
patients, 210 were followed up at 30 days. Six patients were lost
to follow up. Eleven patients died 11(5.1%) patients died. Pre
TpTe interval more than 100 ms predicted (OR 13.21, 95% CI 1.16
e 150.57) increased risk of arrhythmias (Ventricular Tachycardia
and Ventricular Fibrillation). However, it did not predict mor-
tality at 30 days (OR e 1.4, 95% CI e 0.28 e 6.84). After adjusting
for established risk factors, TpTe interval difference (pre e post)
was found to be significantly associated with duration of chest
pain and Killip class.
Conclusion: The TpTe interval was significantly reduced after
reperfusion therapy. Pre-reperfusion TpTe predicted the risk of
arrhythmias at 30 days. However, it did not predict subsequent
all-cause mortality and heart failure at 30 days.
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